Susquehanna International Group, LLP Oncocyte Corp Call Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$0.86 - $1.53 $13,158 - $23,409	-15,300 Reduced 22.43%	52,900 $48,000
Q1 2022 May 16, 2022	SELL	$1.15 - $2.25 $29,784 - $58,275	-25,900 Reduced 27.52%	68,200 $102,000
Q4 2021 Feb 14, 2022	BUY	$2.04 - $3.59 $204 - $359	100 Added 0.11%	94,100 $204,000
Q3 2021 Nov 15, 2021	BUY	$3.53 - $5.89 $73,777 - $123,101	20,900 Added 28.59%	94,000 $335,000
Q2 2021 Aug 11, 2021	BUY	$3.77 - $6.0 $61,828 - $98,400	16,400 Added 28.92%	73,100 $420,000
Q1 2021 May 17, 2021	BUY	$2.39 - $6.5 $85,562 - $232,700	35,800 Added 171.29%	56,700 $294,000
Q4 2020 Feb 16, 2021	BUY	$1.38 - $2.63 $28,841 - $54,967	20,900 New	20,900 $50,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $260M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.